Li Bai-Yan, Chen Hanying, Maruyama Mitsunori, Zhang Wenjun, Zhang Jin, Pan Zhen-Wei, Rubart Michael, Chen Peng-Sheng, Shou Weinian
Department of Pharmacology, Harbin Medical University, 157 Bao Jian Rd, Harbin, 150081, People's Republic of China.
Pediatr Cardiol. 2012 Aug;33(6):988-94. doi: 10.1007/s00246-012-0298-4. Epub 2012 Mar 30.
Specifically, FK506-binding proteins 12 (FKBP12) and 12.6 (FKBP12.6) are cis-trans peptidyl prolyl isomerases that are expressed in the heart. Both FKBP12 and FKBP12.6 were previously known to interact with ryanodine receptors in striated muscles. Although FKBP12 is abundantly present in the heart, its function in the heart is largely uncertain. Recently, by generating FKBP12 transgenic overexpression and cardiac-restricted knockout mice, we showed that FKBP12 is critically important in regulating trans-sarcolemmal ionic currents, predominately the voltage-gated Na+ current, I(Na), but it appears to be less important for regulating cardiac ryanodine receptor function. Similar genetic approaches also confirm the role of FKBP12.6 in regulating cardiac ryanodine receptors. The current study demonstrated that FKBP12 and FKBP12.6 have very different physiologic functions in the heart.
具体而言,FK506结合蛋白12(FKBP12)和12.6(FKBP12.6)是在心脏中表达的顺反肽基脯氨酰异构酶。此前已知FKBP12和FKBP12.6均与横纹肌中的兰尼碱受体相互作用。虽然FKBP12在心脏中大量存在,但其在心脏中的功能在很大程度上尚不确定。最近,通过构建FKBP12转基因过表达和心脏特异性敲除小鼠,我们发现FKBP12在调节跨肌膜离子电流方面至关重要,主要是电压门控性Na+电流I(Na),但它在调节心脏兰尼碱受体功能方面似乎不太重要。类似的遗传学方法也证实了FKBP12.6在调节心脏兰尼碱受体方面的作用。当前研究表明,FKBP12和FKBP12.6在心脏中具有非常不同的生理功能。